News

Initial public offerings scheduled to debut next week

NEW YORK, N.Y. – The following is a list of initial public offerings planned for the coming week. Sources include Renaissance Capital, Greenwich, CT (www.renaissancecapital.com) and SEC filings.

Week of June 17

Bluebird Bio Inc. – Cambridge, Mass., 5 million shares, priced $14 to $16, managed by J.P. Morgan and BofA Merrill Lynch. Proposed Nasdaq symbol BLUE. Business: Developing gene therapies for severe genetic and orphan diseases.

Gogo Inc. – Itasca, Ill., 11 million shares, priced $15 to $17, managed by Morgan Stanley, J.P. Morgan, and UBS. Proposed Nasdaq symbol GOGO. Business: Leading provider of in-flight Wi-Fi.

PTC Therapeutics Inc. – South Plainfield, N.J., 6.9 million shares, priced $13 to $16, managed by J.P. Morgan and Credit Suisse. Proposed Nasdaq symbol PTCT. Business: Biotech targeting rare forms of muscular dystrophy and cystic fibrosis.

Regado Biosciences Inc. – Basking Ridge, N.J., 5 million shares, priced $14 to $16, managed by Cowen & Co. and BMO Capital Markets. Proposed Nasdaq symbol RGDO. Business: Focused on the discovery and development of drugs for cardiovascular indications.

Votorantim Cimentos S.A. – Sao Paulo, Brazil, 200 million American depositary shares, each representing 2 units, priced $15.59 to 18.51, managed by Morgan Stanley, J.P. Morgan, and Itau BBA. Each unit represents 1 common share and 2 preferred shares. Proposed NYSE symbol VEBM. Business: Brazil’s largest cement producer with 37 per cent share.